首页 > 最新文献

Visceral Medicine最新文献

英文 中文
Artificial Intelligence-Augmented Imaging for Early Pancreatic Cancer Detection. 人工智能增强成像用于早期胰腺癌检测。
IF 1.6 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-28 DOI: 10.1159/000546603
Ajith Antony, Sovanlal Mukherjee, Khurram Bhinder, Murlidhar Murlidhar, Armin Zarrintan, Ajit H Goenka

Background: Pancreatic ductal adenocarcinoma (PDA) is a highly lethal malignancy, often diagnosed at an advanced stage due to its insidious progression and the absence of effective early detection strategies. Accurate diagnosis and staging are critical for optimizing treatment selection and improving patient survival. Contrast-enhanced computed tomography (CT) remains the diagnostic standard for PDA; however, its sensitivity is limited by interobserver variability and the frequent absence of overt morphological abnormalities in early stage disease.

Summary: Artificial intelligence (AI) has emerged as a promising tool for overcoming the inherent limitations of conventional radiologic assessment by leveraging radiomics and deep learning models to extract subtle imaging signatures of PDA that are imperceptible to the human eye. AI-driven models have demonstrated the ability to detect pre-diagnostic PDA on CT scans months to years before clinical presentation by identifying textural and structural changes in the pancreas. Furthermore, automated volumetric pancreas segmentation enhances reproducibility and facilitates the discovery of imaging biomarkers associated with early carcinogenesis. Despite these advances, key challenges remain, including dataset heterogeneity, model interpretability, and prospective validation in real-world clinical settings.

Key messages: AI-driven approaches offer a transformative opportunity to augment CT-based PDA detection, reduce diagnostic uncertainty, and facilitate earlier intervention. However, robust external validation, integration into clinical workflows, and prospective trials are essential to establish AI as a reliable adjunct in PDA diagnosis and staging.

背景:胰腺导管腺癌(PDA)是一种高度致命的恶性肿瘤,由于其隐匿的进展和缺乏有效的早期发现策略,通常在晚期诊断。准确的诊断和分期是优化治疗选择和提高患者生存率的关键。对比增强计算机断层扫描(CT)仍然是PDA的诊断标准;然而,它的敏感性受到观察者之间的可变性和在早期疾病中经常没有明显的形态异常的限制。摘要:人工智能(AI)已经成为克服传统放射学评估固有局限性的一种有前途的工具,它利用放射组学和深度学习模型来提取人眼无法察觉的PDA细微成像特征。人工智能驱动的模型已经证明,通过识别胰腺的结构和结构变化,能够在临床表现前数月至数年在CT扫描中发现预诊断的PDA。此外,自动胰腺体积分割提高了可重复性,并有助于发现与早期癌变相关的成像生物标志物。尽管取得了这些进展,但仍存在一些关键挑战,包括数据集的异质性、模型的可解释性以及在现实世界临床环境中的前瞻性验证。关键信息:人工智能驱动的方法提供了一个变革性的机会,增强了基于ct的PDA检测,减少了诊断的不确定性,并促进了早期干预。然而,强大的外部验证、整合到临床工作流程和前瞻性试验对于将人工智能作为PDA诊断和分期的可靠辅助手段至关重要。
{"title":"Artificial Intelligence-Augmented Imaging for Early Pancreatic Cancer Detection.","authors":"Ajith Antony, Sovanlal Mukherjee, Khurram Bhinder, Murlidhar Murlidhar, Armin Zarrintan, Ajit H Goenka","doi":"10.1159/000546603","DOIUrl":"10.1159/000546603","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic ductal adenocarcinoma (PDA) is a highly lethal malignancy, often diagnosed at an advanced stage due to its insidious progression and the absence of effective early detection strategies. Accurate diagnosis and staging are critical for optimizing treatment selection and improving patient survival. Contrast-enhanced computed tomography (CT) remains the diagnostic standard for PDA; however, its sensitivity is limited by interobserver variability and the frequent absence of overt morphological abnormalities in early stage disease.</p><p><strong>Summary: </strong>Artificial intelligence (AI) has emerged as a promising tool for overcoming the inherent limitations of conventional radiologic assessment by leveraging radiomics and deep learning models to extract subtle imaging signatures of PDA that are imperceptible to the human eye. AI-driven models have demonstrated the ability to detect pre-diagnostic PDA on CT scans months to years before clinical presentation by identifying textural and structural changes in the pancreas. Furthermore, automated volumetric pancreas segmentation enhances reproducibility and facilitates the discovery of imaging biomarkers associated with early carcinogenesis. Despite these advances, key challenges remain, including dataset heterogeneity, model interpretability, and prospective validation in real-world clinical settings.</p><p><strong>Key messages: </strong>AI-driven approaches offer a transformative opportunity to augment CT-based PDA detection, reduce diagnostic uncertainty, and facilitate earlier intervention. However, robust external validation, integration into clinical workflows, and prospective trials are essential to establish AI as a reliable adjunct in PDA diagnosis and staging.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-9"},"PeriodicalIF":1.6,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144499483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Intervention in Pediatric Endoscopy: Management of Postsurgical Complications and Bleeding. 儿童内窥镜检查的治疗干预:术后并发症和出血的处理。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-24 DOI: 10.1159/000545893
André Hoerning, Guido Seitz, Dominique Schluckebier, Jan de Laffolie

Background: Pediatric surgical complications and their endoscopic treatment approaches share a unique challenge of small anatomy, highly volatile situations and the need to be flexible with instruments which have been designed for older and bigger patients. In the last few decades, endoscopic interventions have emerged as a minimally invasive alternative approach to standard open closure procedures for the treatment of postsurgical complications.

Summary: This review summarizes the most common situations and techniques in pediatric endoscopy taking on postsurgical complications, including opportunities to improve outcome and overcome barriers of individualized therapy as compared to adult strategies.

Key message: Endoscopic management of postsurgical complications is highly effective and associated with high success rates, low mortality, and minimal recurrence of the underlying pathology.

背景:小儿外科并发症及其内窥镜治疗方法面临着独特的挑战,解剖结构小,情况高度不稳定,需要灵活使用为年龄较大和体型较大的患者设计的器械。在过去的几十年里,内窥镜干预已经成为治疗术后并发症的标准开合手术的一种微创替代方法。摘要:本综述总结了儿科内镜治疗术后并发症的最常见情况和技术,包括与成人策略相比,改善结果和克服个性化治疗障碍的机会。关键信息:内镜下处理术后并发症是非常有效的,具有高成功率、低死亡率和最小的基础病理复发率。
{"title":"Therapeutic Intervention in Pediatric Endoscopy: Management of Postsurgical Complications and Bleeding.","authors":"André Hoerning, Guido Seitz, Dominique Schluckebier, Jan de Laffolie","doi":"10.1159/000545893","DOIUrl":"10.1159/000545893","url":null,"abstract":"<p><strong>Background: </strong>Pediatric surgical complications and their endoscopic treatment approaches share a unique challenge of small anatomy, highly volatile situations and the need to be flexible with instruments which have been designed for older and bigger patients. In the last few decades, endoscopic interventions have emerged as a minimally invasive alternative approach to standard open closure procedures for the treatment of postsurgical complications.</p><p><strong>Summary: </strong>This review summarizes the most common situations and techniques in pediatric endoscopy taking on postsurgical complications, including opportunities to improve outcome and overcome barriers of individualized therapy as compared to adult strategies.</p><p><strong>Key message: </strong>Endoscopic management of postsurgical complications is highly effective and associated with high success rates, low mortality, and minimal recurrence of the underlying pathology.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12215443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery of Early-Stage Pancreatic Cancer. 早期胰腺癌的外科手术。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-15 DOI: 10.1159/000546416
Jelte Poppinga, Alina S Ritter, Kira C Steinkraus, Anna Nießen, Thilo Hackert

Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with early detection and surgical resection being the only potentially curative treatment option. Despite advancements in diagnostics and surgical techniques, the prognosis of early-stage PDAC remains poor. Understanding the indications, approaches and perioperative management are crucial for improving patient survival.

Summary: Surgical resection remains the only curative treatment for early-stage PDAC. Different surgical procedures are performed depending on tumor location and local extent. Advances in minimally invasive surgery (MIS) yielded promising results regarding postoperative recovery and oncologic outcomes. The implementation of neoadjuvant therapy has improved resection and survival rates. Still, pancreatic surgery is associated with significant morbidity.

Key messages: Surgical resection remains the only curative option for early-stage pancreatic cancer. Neoadjuvant chemotherapy plays a crucial role in improving resection and survival rates. Perioperative care has been refined by MIS, optimized surgical techniques, and structured complication management.

背景:胰腺导管腺癌(PDAC)仍然是最致命的恶性肿瘤之一,早期发现和手术切除是唯一可能治愈的治疗选择。尽管诊断和手术技术的进步,早期PDAC的预后仍然很差。了解适应证、入路和围手术期管理对提高患者生存率至关重要。总结:手术切除仍然是治疗早期PDAC的唯一方法。根据肿瘤的位置和局部范围,采取不同的手术方法。微创手术(MIS)的进步在术后恢复和肿瘤预后方面取得了可喜的结果。新辅助治疗的实施提高了切除率和生存率。尽管如此,胰腺手术仍与显著的发病率相关。关键信息:手术切除仍然是早期胰腺癌的唯一治疗选择。新辅助化疗对提高肿瘤的切除率和生存率起着至关重要的作用。围手术期护理已通过MIS、优化的手术技术和结构化的并发症管理得到完善。
{"title":"Surgery of Early-Stage Pancreatic Cancer.","authors":"Jelte Poppinga, Alina S Ritter, Kira C Steinkraus, Anna Nießen, Thilo Hackert","doi":"10.1159/000546416","DOIUrl":"10.1159/000546416","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with early detection and surgical resection being the only potentially curative treatment option. Despite advancements in diagnostics and surgical techniques, the prognosis of early-stage PDAC remains poor. Understanding the indications, approaches and perioperative management are crucial for improving patient survival.</p><p><strong>Summary: </strong>Surgical resection remains the only curative treatment for early-stage PDAC. Different surgical procedures are performed depending on tumor location and local extent. Advances in minimally invasive surgery (MIS) yielded promising results regarding postoperative recovery and oncologic outcomes. The implementation of neoadjuvant therapy has improved resection and survival rates. Still, pancreatic surgery is associated with significant morbidity.</p><p><strong>Key messages: </strong>Surgical resection remains the only curative option for early-stage pancreatic cancer. Neoadjuvant chemotherapy plays a crucial role in improving resection and survival rates. Perioperative care has been refined by MIS, optimized surgical techniques, and structured complication management.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-7"},"PeriodicalIF":1.8,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computed Tomography Texture Analysis of Lymph Nodes for Improved Staging Accuracy in Patients with Colon Cancer. 淋巴结的ct纹理分析提高结肠癌患者分期准确性。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-14 DOI: 10.1159/000546336
Jakob Leonhardi, Matthias Mehdorn, Sigmar Stelzner, Uwe Scheuermann, Anne-Kathrin Höhn, Daniel Seehofer, Timm Denecke, Hans-Jonas Meyer

Introduction: Texture analysis can provide quantitative imaging markers and better characterize tumor tissue in oncological imaging. The present analysis investigated the diagnostic benefit of computed tomography (CT)-derived texture analysis to categorize and stage lymph nodes in patients with colon cancer.

Methods: In this study, 85 patients were included (n = 39 females, 45.9%) with a mean age of 70.3 ± 14.8 years. All patients were surgically resected, and the lymph nodes were histopathologically analyzed. All investigated lymph nodes were further investigated with texture analysis using the MaZda package.

Results: Out of a total of 279 extracted CT texture features, 7 parameters independently showed statistically significant differences between lymph node positive to negative ones. For instance, the texture parameter S(1,0)AngScMom showed statistically significant differences regarding lymph node metastasis status (0.007 ± 0.004 for N0 vs. 0.005 ± 0.001 for N1-2, p = 0.001). A multivariate model was developed based on n = 7 independent texture parameters. The diagnostic accuracy reached an area under the curve of 0.79 (95% CI: 0.69-0.89) with a sensitivity of 0.77 and a specificity of 0.70, resulting in an accuracy of 0.73.

Discussion: Texture analysis can improve the diagnostic accuracy for nodal CT staging in patients with colon cancer. Further validation studies are needed to confirm the present results.

在肿瘤成像中,纹理分析可以提供定量的成像标记,更好地表征肿瘤组织。本分析探讨了计算机断层扫描(CT)衍生的纹理分析对结肠癌患者淋巴结的分类和分期的诊断价值。方法:85例患者(女性39例,占45.9%),平均年龄70.3±14.8岁。所有患者均行手术切除,并对淋巴结进行组织病理学分析。所有被调查的淋巴结进一步调查纹理分析使用马自达包。结果:在提取的279个CT纹理特征中,有7个参数在淋巴结阳性与阴性之间独立存在统计学差异。例如,纹理参数S(1,0)AngScMom在淋巴结转移状态方面存在统计学差异(N0为0.007±0.004,N1-2为0.005±0.001,p = 0.001)。基于n = 7个独立纹理参数建立多元模型。诊断准确度达到曲线下面积0.79 (95% CI: 0.69-0.89),敏感性0.77,特异性0.70,准确度0.73。讨论:纹理分析可提高结肠癌患者淋巴结CT分期的诊断准确性。需要进一步的验证研究来证实目前的结果。
{"title":"Computed Tomography Texture Analysis of Lymph Nodes for Improved Staging Accuracy in Patients with Colon Cancer.","authors":"Jakob Leonhardi, Matthias Mehdorn, Sigmar Stelzner, Uwe Scheuermann, Anne-Kathrin Höhn, Daniel Seehofer, Timm Denecke, Hans-Jonas Meyer","doi":"10.1159/000546336","DOIUrl":"10.1159/000546336","url":null,"abstract":"<p><strong>Introduction: </strong>Texture analysis can provide quantitative imaging markers and better characterize tumor tissue in oncological imaging. The present analysis investigated the diagnostic benefit of computed tomography (CT)-derived texture analysis to categorize and stage lymph nodes in patients with colon cancer.</p><p><strong>Methods: </strong>In this study, 85 patients were included (<i>n</i> = 39 females, 45.9%) with a mean age of 70.3 ± 14.8 years. All patients were surgically resected, and the lymph nodes were histopathologically analyzed. All investigated lymph nodes were further investigated with texture analysis using the MaZda package.</p><p><strong>Results: </strong>Out of a total of 279 extracted CT texture features, 7 parameters independently showed statistically significant differences between lymph node positive to negative ones. For instance, the texture parameter S(1,0)AngScMom showed statistically significant differences regarding lymph node metastasis status (0.007 ± 0.004 for N0 vs. 0.005 ± 0.001 for N1-2, <i>p</i> = 0.001). A multivariate model was developed based on <i>n</i> = 7 independent texture parameters. The diagnostic accuracy reached an area under the curve of 0.79 (95% CI: 0.69-0.89) with a sensitivity of 0.77 and a specificity of 0.70, resulting in an accuracy of 0.73.</p><p><strong>Discussion: </strong>Texture analysis can improve the diagnostic accuracy for nodal CT staging in patients with colon cancer. Further validation studies are needed to confirm the present results.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-8"},"PeriodicalIF":1.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144499484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Management of Postsurgical Complications after Metabolic and Bariatric Surgery. 代谢和减肥手术后并发症的内镜处理。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-08 DOI: 10.1159/000546193
Christine Stier, Sebastian Belle, Patrick Téoule

Background: Following metabolic and bariatric surgery (MBS), a wide range of symptoms may indicate postoperative complications, all of which can prompt endoscopic inspection and multidisciplinary management of potential complications. Therefore, an anatomical and technical understanding of the previous surgical procedure and its forms of reconstruction especially after MBS is crucial for the attending endoscopist to optimize endoluminal therapy. A selective literature review has been performed. This overview of endoscopic complication management aims to outline the available options after MBS.

Summary: Postoperative complication rates vary widely depending on the antecedent procedure and have been reported to be relevant after specific procedures such as laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass in the context of MBS. There is a timeline of 30 days in the postoperative course that divides early from late complications. While anastomotic leaks or endoluminal bleeding are considered typical early complications, late complications include problems such as strictures and anastomotic ulcers. Management of complications in the immediate postoperative period (very early complications) may require a multidisciplinary approach to optimize the outcome of complication management, involving the surgeon, the endoscopist and the ward physician who manages the patient round-the-clock. This hand-in-hand approach enables the best possible treatment for the patient, with endoscopy playing a crucial role in solving endoluminal problems in a much less invasive way than repeated surgical intervention, thereby contributing significantly to an easier postoperative course.

Key messages: The surgical approach, in cooperation with endoluminal complication management, constitutes comprehensive visceral medicine, as endoscopy is the helping hand of surgery in the context of MBS.

背景:代谢和减肥手术(MBS)后,广泛的症状可能提示术后并发症,所有这些都可以提示内镜检查和潜在并发症的多学科管理。因此,对以往的外科手术及其重建形式的解剖学和技术理解,特别是在MBS后,对于主治内镜医师优化腔内治疗至关重要。进行了选择性的文献综述。本内镜并发症管理概述旨在概述MBS后可用的选择。摘要:术后并发症的发生率因术前手术的不同而有很大差异,据报道,在MBS背景下,腹腔镜袖胃切除术或Roux-en-Y胃旁路术等特定手术后并发症发生率也有相关性。术后有一个30天的时间线来区分早期和晚期并发症。虽然吻合口瘘或腔内出血被认为是典型的早期并发症,但晚期并发症包括狭窄和吻合口溃疡等问题。术后早期并发症的管理可能需要多学科的方法来优化并发症管理的结果,包括外科医生、内窥镜医师和全天候管理患者的病房医生。这种手拉手的方法可以为患者提供最好的治疗,内窥镜检查在解决腔内问题方面发挥着至关重要的作用,比重复的手术干预侵入性小得多,从而大大简化了术后过程。关键信息:手术入路,配合腔内并发症的处理,构成了全面的内脏医学,因为内镜是MBS背景下手术的帮手。
{"title":"Endoscopic Management of Postsurgical Complications after Metabolic and Bariatric Surgery.","authors":"Christine Stier, Sebastian Belle, Patrick Téoule","doi":"10.1159/000546193","DOIUrl":"10.1159/000546193","url":null,"abstract":"<p><strong>Background: </strong>Following metabolic and bariatric surgery (MBS), a wide range of symptoms may indicate postoperative complications, all of which can prompt endoscopic inspection and multidisciplinary management of potential complications. Therefore, an anatomical and technical understanding of the previous surgical procedure and its forms of reconstruction especially after MBS is crucial for the attending endoscopist to optimize endoluminal therapy. A selective literature review has been performed. This overview of endoscopic complication management aims to outline the available options after MBS.</p><p><strong>Summary: </strong>Postoperative complication rates vary widely depending on the antecedent procedure and have been reported to be relevant after specific procedures such as laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass in the context of MBS. There is a timeline of 30 days in the postoperative course that divides early from late complications. While anastomotic leaks or endoluminal bleeding are considered typical early complications, late complications include problems such as strictures and anastomotic ulcers. Management of complications in the immediate postoperative period (very early complications) may require a multidisciplinary approach to optimize the outcome of complication management, involving the surgeon, the endoscopist and the ward physician who manages the patient round-the-clock. This hand-in-hand approach enables the best possible treatment for the patient, with endoscopy playing a crucial role in solving endoluminal problems in a much less invasive way than repeated surgical intervention, thereby contributing significantly to an easier postoperative course.</p><p><strong>Key messages: </strong>The surgical approach, in cooperation with endoluminal complication management, constitutes comprehensive visceral medicine, as endoscopy is the helping hand of surgery in the context of MBS.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-15"},"PeriodicalIF":1.8,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound Diagnostics in Alveolar Echinococcosis: An Update. 肺泡包虫病的超声诊断:最新进展。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-03 DOI: 10.1159/000545080
Wolfgang Kratzer

Background: Alveolar echinococcosis (AE) is a rare, potentially fatal zoonosis. In recent years, imaging diagnostics have become increasingly important compared to serologic diagnostics in AE. We will provide an overview of the importance of ultrasound diagnostics in AE in the detection of the disease and its significance in follow-up, as well as the typical sonographic presentation patterns and pitfalls.

Summary: The use of the ultrasound classification developed by us and the use of contrast-enhanced ultrasound (CEUS) helps make the diagnosis faster and better. Without CEUS, the hemangioma-like pattern and the metastasis-like pattern in particular cannot be diagnosed with certainty. The limitations of ultrasound diagnostics on the patient side, in terms of examiner experience and equipment, remain.

Key messages: Ultrasound is an important procedure in the detection and follow-up of AE. Contrast-enhanced sonography is indispensable. Fundamental limitations of ultrasound diagnostics such as examiner experience remain.

背景:肺泡棘球蚴病(AE)是一种罕见的、潜在致命的人畜共患病。近年来,与血清学诊断相比,影像学诊断在AE中变得越来越重要。我们将概述超声诊断在AE疾病检测中的重要性及其在随访中的意义,以及典型的超声表现模式和陷阱。总结:采用我们开发的超声分类和超声造影(CEUS)有助于更快更好的诊断。如果没有超声造影,血管瘤样模式,尤其是转移样模式不能确定诊断。超声诊断在患者方面的局限性,在检查经验和设备方面,仍然存在。关键信息:超声是AE检测和随访的重要手段。对比增强超声检查是必不可少的。超声诊断的基本限制,如检查者的经验仍然存在。
{"title":"Ultrasound Diagnostics in Alveolar Echinococcosis: An Update.","authors":"Wolfgang Kratzer","doi":"10.1159/000545080","DOIUrl":"10.1159/000545080","url":null,"abstract":"<p><strong>Background: </strong>Alveolar echinococcosis (AE) is a rare, potentially fatal zoonosis. In recent years, imaging diagnostics have become increasingly important compared to serologic diagnostics in AE. We will provide an overview of the importance of ultrasound diagnostics in AE in the detection of the disease and its significance in follow-up, as well as the typical sonographic presentation patterns and pitfalls.</p><p><strong>Summary: </strong>The use of the ultrasound classification developed by us and the use of contrast-enhanced ultrasound (CEUS) helps make the diagnosis faster and better. Without CEUS, the hemangioma-like pattern and the metastasis-like pattern in particular cannot be diagnosed with certainty. The limitations of ultrasound diagnostics on the patient side, in terms of examiner experience and equipment, remain.</p><p><strong>Key messages: </strong>Ultrasound is an important procedure in the detection and follow-up of AE. Contrast-enhanced sonography is indispensable. Fundamental limitations of ultrasound diagnostics such as examiner experience remain.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-7"},"PeriodicalIF":1.8,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12143886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Detection of Pancreatic Cancer. 早期发现胰腺癌。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-03 DOI: 10.1159/000546203
Hans Scherübl, Thilo Hackert
{"title":"Early Detection of Pancreatic Cancer.","authors":"Hans Scherübl, Thilo Hackert","doi":"10.1159/000546203","DOIUrl":"10.1159/000546203","url":null,"abstract":"","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-3"},"PeriodicalIF":1.8,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12148335/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144267952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Focal Pancreatic Parenchymal Atrophy: An Alternative Indicator for Early-Stage Pancreatic Cancer. 局灶性胰腺实质萎缩:早期胰腺癌的另一项指标。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1159/000545847
Masataka Kikuyama

Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a poor prognosis, with a high mortality rate often attributed to its late-stage diagnosis. Early detection remains paramount in improving survival outcomes for affected individuals.

Summary: The prognosis of PDAC can be significantly improved if the cancer is diagnosed at an early stage, specifically when it remains localized to the ductal epithelium. This early stage is commonly referred to as high-grade pancreatic intraepithelial neoplasia (HG-PanIN) or carcinoma in situ (CIS, stage 0). At this stage, metastasis has not yet occurred, offering the potential for more effective therapeutic interventions. Focal pancreatic parenchymal atrophy (FPPA) has emerged as a crucial radiological and pathological feature suggestive of HG-PanIN/CIS.

Key message: Accurate identification of FPPA is critical for diagnosing HG-PanIN and CIS, both of which represent preinvasive stages of PDAC. Given the implications of early detection, serial pancreatic juice cytologic examination is recommended for patients exhibiting FPPA to facilitate timely diagnosis and intervention.

背景:胰腺导管腺癌(Pancreatic ductal adenocarcinoma, PDAC)的特点是预后差,死亡率高,通常归因于其晚期诊断。早期发现对于改善受影响个体的生存结果仍然至关重要。总结:如果早期诊断出PDAC,特别是当肿瘤局限于导管上皮时,其预后可以显著改善。这个早期阶段通常被称为高级别胰腺上皮内瘤变(HG-PanIN)或原位癌(CIS, 0期)。在这个阶段,转移尚未发生,提供了更有效的治疗干预的潜力。局灶性胰腺实质萎缩(FPPA)已成为HG-PanIN/CIS的重要影像学和病理学特征。关键信息:准确识别FPPA对于诊断HG-PanIN和CIS至关重要,两者都代表PDAC的侵袭前阶段。考虑到早期发现的意义,建议对出现FPPA的患者进行连续的胰液细胞学检查,以便及时诊断和干预。
{"title":"Focal Pancreatic Parenchymal Atrophy: An Alternative Indicator for Early-Stage Pancreatic Cancer.","authors":"Masataka Kikuyama","doi":"10.1159/000545847","DOIUrl":"10.1159/000545847","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic ductal adenocarcinoma (PDAC) is characterized by a poor prognosis, with a high mortality rate often attributed to its late-stage diagnosis. Early detection remains paramount in improving survival outcomes for affected individuals.</p><p><strong>Summary: </strong>The prognosis of PDAC can be significantly improved if the cancer is diagnosed at an early stage, specifically when it remains localized to the ductal epithelium. This early stage is commonly referred to as high-grade pancreatic intraepithelial neoplasia (HG-PanIN) or carcinoma in situ (CIS, stage 0). At this stage, metastasis has not yet occurred, offering the potential for more effective therapeutic interventions. Focal pancreatic parenchymal atrophy (FPPA) has emerged as a crucial radiological and pathological feature suggestive of HG-PanIN/CIS.</p><p><strong>Key message: </strong>Accurate identification of FPPA is critical for diagnosing HG-PanIN and CIS, both of which represent preinvasive stages of PDAC. Given the implications of early detection, serial pancreatic juice cytologic examination is recommended for patients exhibiting FPPA to facilitate timely diagnosis and intervention.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-6"},"PeriodicalIF":1.8,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Management of Biliary Leakages. 胆道渗漏的内镜治疗。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1159/000545742
Mark Ellrichmann, Jannes Bösenkötter, Stephan Schoch, Claudio Cim Conrad

Background: Biliary leakages are notable complications that can occur following hepatobiliary surgery, traumatic injury, or iatrogenic causes related to medical interventions. The management of biliary leaks is critical as untreated leaks can result in severe complications such as biliary peritonitis, abscess formation, and sepsis.

Summary: Treatment approaches for biliary leaks are highly variable and depend on the severity and anatomical location of the leak. Options range from conservative management and endoscopic interventions to surgical repair in more severe cases. A clear understanding of the classification of biliary leaks - whether anatomical, etiological, or severity-based - is essential to guide appropriate treatment strategies and improve clinical outcomes. Notably, several endoscopic techniques are now available and have significantly enhanced patient outcomes, even in complex surgical anatomies.

Key messages: The management of biliary duct leaks requires a comprehensive approach that includes endoscopic, percutaneous, and surgical interventions. The choice of treatment is determined by the severity of the leak, the patient's overall condition, and the specific context of the injury. Endoscopic retrograde cholangiopancreatography in combination with sphincterotomy and stent placement is widely regarded as the first-line treatment when the papilla is conventionally accessible.

背景:胆道渗漏是肝胆外科手术、外伤性损伤或与医疗干预相关的医源性原因后可能发生的显著并发症。胆道渗漏的处理是至关重要的,因为未经治疗的渗漏会导致严重的并发症,如胆道性腹膜炎、脓肿形成和败血症。摘要:胆道泄漏的治疗方法是高度可变的,取决于泄漏的严重程度和解剖位置。选择范围从保守管理和内窥镜干预到更严重病例的手术修复。清楚地了解胆道渗漏的分类-无论是解剖学,病因学还是基于严重程度-对于指导适当的治疗策略和改善临床结果至关重要。值得注意的是,现在有几种内窥镜技术,即使在复杂的外科解剖中,也能显著提高患者的预后。关键信息:胆管泄漏的管理需要综合的方法,包括内镜,经皮和手术干预。治疗的选择取决于泄漏的严重程度、患者的整体状况和损伤的具体情况。内镜逆行胆管造影联合括约肌切开术和支架置入术被广泛认为是常规可及乳头的一线治疗方法。
{"title":"Endoscopic Management of Biliary Leakages.","authors":"Mark Ellrichmann, Jannes Bösenkötter, Stephan Schoch, Claudio Cim Conrad","doi":"10.1159/000545742","DOIUrl":"10.1159/000545742","url":null,"abstract":"<p><strong>Background: </strong>Biliary leakages are notable complications that can occur following hepatobiliary surgery, traumatic injury, or iatrogenic causes related to medical interventions. The management of biliary leaks is critical as untreated leaks can result in severe complications such as biliary peritonitis, abscess formation, and sepsis.</p><p><strong>Summary: </strong>Treatment approaches for biliary leaks are highly variable and depend on the severity and anatomical location of the leak. Options range from conservative management and endoscopic interventions to surgical repair in more severe cases. A clear understanding of the classification of biliary leaks - whether anatomical, etiological, or severity-based - is essential to guide appropriate treatment strategies and improve clinical outcomes. Notably, several endoscopic techniques are now available and have significantly enhanced patient outcomes, even in complex surgical anatomies.</p><p><strong>Key messages: </strong>The management of biliary duct leaks requires a comprehensive approach that includes endoscopic, percutaneous, and surgical interventions. The choice of treatment is determined by the severity of the leak, the patient's overall condition, and the specific context of the injury. Endoscopic retrograde cholangiopancreatography in combination with sphincterotomy and stent placement is widely regarded as the first-line treatment when the papilla is conventionally accessible.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-8"},"PeriodicalIF":1.8,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12194304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144509580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Options for Complications after Pancreatic Surgery. 胰腺手术后并发症的内镜选择。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-04-21 DOI: 10.1159/000545766
Jörn Bernhardt, Sylke Schneider-Koriath, Kaja Ludwig

Background: The shift in surgery is taking place in two directions. On the one hand, it is shifting from open surgery to minimally invasive surgery which will ultimately morph into robot-assisted surgery. On the other hand, the therapeutic possibilities of flexible endoscopy have developed enormously in recent years. Various procedures, such as the debridement of pancreatic necrosis, the resection of early neoplasms, the treatment of achalasia, or the resection of numerous submucosal tumors, have passed into the hands of the interventional endoscopist. Endoscopic procedures have also become established in the management of complications of major intestinal procedures. Despite the fact that endoscopic therapy requires time to heal, for example, in VAC therapy, it being less invasive reduces patient morbidity.

Summary: The most common complications in modern pancreatic surgery are pancreatogenic fistulas and fluid collections, as well as insufficiencies of pancreatointestinal or biliodigestive anastomoses. Such complications can be treated endoscopically using methods such as stent placement in the pancreatic or bile duct, endosonographically guided drainage of fluid collections, and even VAC therapy.

Key messages: Endoscopic intervention is the first procedure of choice offered in the treatment of complications in pancreatic surgery. It primarily reduces morbidity in the recovery phase of patients.

背景:外科手术的转变发生在两个方向上。一方面,它正在从开放手术向微创手术转变,微创手术最终将演变为机器人辅助手术。另一方面,近年来柔性内窥镜的治疗可能性有了很大的发展。各种手术,如胰腺坏死的清创,早期肿瘤的切除,贲门失弛缓症的治疗,或许多粘膜下肿瘤的切除,已经交给了介入内窥镜医生。内窥镜手术也已成为主要肠道手术并发症的治疗方法。尽管内窥镜治疗需要时间来愈合,例如,在VAC治疗中,它的侵入性较小,减少了患者的发病率。摘要:现代胰腺手术中最常见的并发症是胰源性瘘和积液,以及胰肠或胆消化吻合不全。这些并发症可以在内镜下治疗,如在胰管或胆管内放置支架,在超声引导下引流积液,甚至是真空通气治疗。内镜介入是胰腺手术并发症治疗的首选方法。它主要降低患者恢复期的发病率。
{"title":"Endoscopic Options for Complications after Pancreatic Surgery.","authors":"Jörn Bernhardt, Sylke Schneider-Koriath, Kaja Ludwig","doi":"10.1159/000545766","DOIUrl":"10.1159/000545766","url":null,"abstract":"<p><strong>Background: </strong>The shift in surgery is taking place in two directions. On the one hand, it is shifting from open surgery to minimally invasive surgery which will ultimately morph into robot-assisted surgery. On the other hand, the therapeutic possibilities of flexible endoscopy have developed enormously in recent years. Various procedures, such as the debridement of pancreatic necrosis, the resection of early neoplasms, the treatment of achalasia, or the resection of numerous submucosal tumors, have passed into the hands of the interventional endoscopist. Endoscopic procedures have also become established in the management of complications of major intestinal procedures. Despite the fact that endoscopic therapy requires time to heal, for example, in VAC therapy, it being less invasive reduces patient morbidity.</p><p><strong>Summary: </strong>The most common complications in modern pancreatic surgery are pancreatogenic fistulas and fluid collections, as well as insufficiencies of pancreatointestinal or biliodigestive anastomoses. Such complications can be treated endoscopically using methods such as stent placement in the pancreatic or bile duct, endosonographically guided drainage of fluid collections, and even VAC therapy.</p><p><strong>Key messages: </strong>Endoscopic intervention is the first procedure of choice offered in the treatment of complications in pancreatic surgery. It primarily reduces morbidity in the recovery phase of patients.</p>","PeriodicalId":56003,"journal":{"name":"Visceral Medicine","volume":" ","pages":"1-8"},"PeriodicalIF":1.8,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12119102/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144182061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Visceral Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1